Effect of testosterone deprivation on expression of the androgen receptor in rat prostate, epididymis and testis
Open Access
- 1 April 1992
- journal article
- Published by Wiley in International Journal of Andrology
- Vol. 15 (2) , 182-198
- https://doi.org/10.1111/j.1365-2605.1992.tb01125.x
Abstract
Adult rats were treated with ethane dimethane sulphonate (EDS) to eliminate the Leydig cells. This treatment resulted in very low levels of testosterone in the blood and in the testis. Furthermore, histological evaluation of spermatogenesis showed no marked differences between control and EDS-treated animals. In the ventral prostate, 5 days after EDS-treatment, a 4.0 ± 0.3–fold up-regulation of androgen receptor (AR) mRNA was observed, together with a 2.2 ± 0.2–fold increase in actin mRNA. In the epididymis, a 2.0 ± 0.5–fold increase in AR mRNA level was observed, without a change in actin mRNA level. In the testes of EDS-treated rats, the AR mRNA level was not changed (1.02 ± 0.17–fold of controls), and there was also no change in actin mRNA level at 5 days after EDS-treatment. These results indicate that AR mRNA expression in the ventral prostate and epididymis is regulated differentially by testosterone when compared to regulation in the testis. Testicular androgen binding sites were assayed by Scatchard analysis of the binding of 3H-R1881 to a nuclear fraction, that was isolated by a method which involved the use of liquid nitrogen and high sucrose buffer. The number of specific binding sites per testis in EDS-treated rats with testosterone-implants, remained unaltered compared to control rats (9.1 ± 1.4 pmol/testis). In these rats, 20% of the normal testicular testosterone level was sufficient to maintain the androgen receptor in a tight nuclear binding (transformed) form. In testes from EDS-treated rats without testosterone-implants, the AR did not fractionate into the nuclear fraction; however, the total testicular AR content in these animals was close to control levels, as measured by nuclear 3H-R1881 binding after receptor transformation through injection of a high dose of testosterone (10 mg) 2 h before killing the rats (testosterone pulse). In the different experimental groups, FSH was not required to maintain the total testicular AR content (ligand binding).Keywords
This publication has 31 references indexed in Scilit:
- Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cellsMolecular and Cellular Endocrinology, 1991
- The rat androgen receptor gene promoterMolecular and Cellular Endocrinology, 1990
- Synergistic effect of testosterone and of a luteinizing hormone-releasing hormone agonist on androgen receptor content in the ventral prostate of castrated ratsSteroids, 1989
- Increase in Testicular Androgen Receptor during Sexual Maturation in the Rat1Biology of Reproduction, 1988
- Cloning, structure and expression of a cDNA encoding the human androgen receptorBiochemical and Biophysical Research Communications, 1988
- Re-evaluation of the intratesticular level of testosterone required for quantitative maintenance of spermatogenesis in the ratJournal of Endocrinology, 1988
- Tissue-specific in vitro transcription from the mouse albumin promoterCell, 1986
- Cyproterone acetate prevents translocation of the androgen receptor in the rat prostateMolecular and Cellular Endocrinology, 1983
- Purification of Mouse Immunoglobulin Heavy‐Chain Messenger RNAs from Total Myeloma Tumor RNAEuropean Journal of Biochemistry, 1980
- Effects of Hormones on Spermatogenesis in the RatPublished by Wiley ,1967